NASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $125.16 +1.85 (+1.50%) Closing price 04:00 PM EasternExtended Trading$125.22 +0.06 (+0.05%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Mesa Laboratories Stock (NASDAQ:MLAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$122.52▼$128.2750-Day Range$106.04▼$142.2352-Week Range$69.51▼$144.35Volume77,216 shsAverage Volume110,098 shsMarket Capitalization$700.40 millionP/E Ratio149.00Dividend Yield0.51%Price Target$110.00Consensus RatingHold Company Overview Mesa Laboratories, Inc. (NASDAQ:MLAB) develops, manufactures and sells products used for quality control, safety monitoring and process validation across healthcare, pharmaceutical, industrial and research markets. The company’s offerings are designed to help customers monitor critical conditions and verify that sterilization, radiation exposure and other controlled processes meet established standards. Mesa Laboratories’ products include biological and chemical indicators, process challenge devices and related systems for sterilization monitoring. These products are used to assess the effectiveness of sterilization processes in hospitals, laboratories, pharmaceutical manufacturing and other healthcare settings. The company also provides dosimetry products and services that monitor occupational exposure to radiation. Additional product lines support dialysis and renal-care applications, including testing and monitoring equipment used to evaluate water quality and treatment processes. Mesa Laboratories serves customers in the United States and international markets through direct sales, distributors and specialized industry channels. The company is headquartered in Colorado and has built its business through the development of specialized monitoring technologies and related acquisitions.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreMLAB MarketRank™: 1.403695334305 of 5 starsMesa Laboratories scored higher than 28% of companies evaluated by MarketBeat, and ranked 714th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingMesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.Downside RiskMesa Laboratories has a consensus price target of $110.00, representing about 12.1% downside from its current price of $125.16.Amount of Analyst CoverageMesa Laboratories has only been the subject of 2 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is 149.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is 149.00, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.74.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 3.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Mesa Laboratories' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.22% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently increased by 10.78%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories has a dividend yield of 0.52%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mesa Laboratories is 76.19%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Mesa Laboratories' dividend. News and Social Media1.4 / 5News SentimentN/A News SentimentMesa Laboratories has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Mesa Laboratories this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for MLAB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership4.4 / 5Insider TradingAcquiring Shares Cluster Insider Buying2 insiders have purchased shares of Mesa Laboratories in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $102,321.00 in company stock, which represents 0.0146% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have bought 12.79% more of their company's stock than they have sold. Specifically, they have bought $902,411.00 in company stock and sold $800,090.00 in company stock.Percentage Held by Insiders2.80% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesWeekly Buzz: RHHBY, TEVA Win FDA Nod; MLAB, GSK Cut Jobs; AZN, VIR Deals; KRYS, ABBV Report DataOctober 16, 2026 | rttnews.comMesa Laboratories to Lay Off 40 Positions; Targets $9.3 Million Annual Cost ReductionOctober 13, 2026 | finance.yahoo.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.October 20 at 1:00 AM | Brownstone Research (Ad)Mesa Laboratories To Cut 40 Jobs, Plan $9.3 Mln Cost SavingsOctober 13, 2026 | rttnews.comMesa Laboratories announces $9.3M cost-savings planOctober 13, 2026 | msn.comMesa Laboratories Announces Global Restructuring and Cost SavingsOctober 13, 2026 | tipranks.comMesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable GrowthOctober 13, 2026 | globenewswire.comMesa Laboratories Shareholders Back Board And Governance DecisionsSeptember 8, 2026 | tipranks.comSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $78.50 at the start of the year. Since then, MLAB shares have increased by 59.4% and is now trading at $125.16. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings data on Monday, August, 10th. The medical instruments supplier reported $2.68 EPS for the quarter. The medical instruments supplier earned $60.14 million during the quarter. Mesa Laboratories had a net margin of 1.92% and a trailing twelve-month return on equity of 22.72%. Read the conference call transcript. Who are Mesa Laboratories' major shareholders? Mesa Laboratories' top institutional investors include Burns Matteson Capital Management LLC (0.05%). Insiders that own company stock include Gary M Owens, John Sakys, John James Sullivan, Shiraz Shabanali Ladiwala, Siddhartha Kadia, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include Intel (INTC), NVIDIA (NVDA), Walt Disney (DIS), Lennar (LEN), Southwest Airlines (LUV), Advanced Micro Devices (AMD) and Gilead Sciences (GILD). Company Calendar Last Earnings8/10/2026Record date for 9/15 Dividend8/31/2026Ex-Dividend for 9/15 Dividend8/31/2026Dividend Payable9/15/2026Today10/20/2026Next Earnings (Estimated)11/05/2026Record date for 12/15 Dividend11/30/2026Ex-Dividend for 12/15 Dividend11/30/2026Dividend Payable12/15/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 MLAB's financial health is in the Green zone, according to TradeSmith. MLAB has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees717Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$110.00 High Price Target$110.00 Low Price Target$110.00 Potential Upside/Downside-12.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.84 Trailing P/E Ratio149.00 Forward P/E RatioN/A P/E GrowthN/ANet Income$6.71 million Net Margins1.92% Pretax Margin3.75% Return on Equity22.72% Return on Assets9.82% Debt Debt-to-Equity Ratio0.73 Current Ratio1.79 Quick Ratio1.32 Sales & Book Value Annual Sales$249.73 million Price / Sales2.80 Cash Flow$11.95 per share Price / Cash Flow10.47 Book Value$33.71 per share Price / Book3.71Miscellaneous Outstanding Shares5,596,000Free Float5,439,000Market Cap$700.40 million OptionableNot Optionable Beta1.06 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:MLAB) was last updated on 10/20/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredBuy These Five AI Plays Before October 20Jeff Brown, founder and CEO of Brownstone Research, says a new market cycle he calls the million dollar cycle ...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredPalantir and Wall Street are in on it…Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
